who makes glp 1 drugs GLP-1s for Weight Loss: What You Need to Know GLP-1 drugs can help you

CMS GLP-1 Bridge Program: Medicare Part D coverage for weight-loss GLP-1 drugs starting July 1, 2026, including eligibility, covered medications, prior authorization, and copay rules.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved a new indication for Wegovy (semaglutide) to reduce the risk of overweight and obese adults suffering serious heart problems or strokes.

From a scientific breakthrough studying the oft fasting Gila Monster has become the current successful weight loss therapies, here's how.

Studies show GLP-1 reduces glucagon levels and improves glucose regulation

GLP-1 2.0: where will the next wave of value come from

GLP-1RA medications are the first pharmacotherapy for obesity with demonstrable cardiovascular benefits and ASCVD risk reduction